AbbVie Inc.
ABBV
$245.66
$1.860.76%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 285.18% | -45.96% | 8,354.55% | -88.08% | -31.53% |
| Total Depreciation and Amortization | -8.15% | -5.05% | -5.47% | -0.77% | -3.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -75.76% | 250.56% | -64.81% | 233.21% | 26.72% |
| Change in Net Operating Assets | -384.16% | 25.50% | -19.14% | 67.07% | 83.38% |
| Cash from Operations | -33.32% | 134.19% | -25.96% | 28.95% | 126.90% |
| Capital Expenditure | -19.70% | -12.77% | -13.06% | -53.01% | -11.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 12.34% | 50.56% | 35.21% | 67.01% | -11.51% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -282.14% | -213.16% | -87.08% | -116.67% | 255.56% |
| Cash from Investing | -1.35% | 21.90% | 21.93% | 60.47% | -7.17% |
| Total Debt Issued | -100.00% | 43.03% | -125.00% | -- | -- |
| Total Debt Repaid | 46.72% | 17.42% | 86.13% | -400.25% | -12.13% |
| Issuance of Common Stock | -- | -- | 380.00% | -5.97% | -- |
| Repurchase of Common Stock | 25.00% | -54.94% | 99.16% | 76.47% | -33.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.50% | -5.50% | -5.78% | -5.82% | -5.82% |
| Other Financing Activities | 733.33% | -97.01% | -200.00% | 15.63% | -- |
| Cash from Financing | -86.49% | 173.05% | 39.28% | -49.41% | 55.55% |
| Foreign Exchange rate Adjustments | -123.33% | -233.33% | 123.91% | -200.00% | 433.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -318.42% | 1,292.55% | 76.92% | 85.73% | 126.17% |